Xencor Inc (XNCR)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 951,945 | 983,635 | 826,167 | 884,255 | 952,692 | 778,430 | 778,121 | 803,411 | 846,266 | 835,269 | 851,325 | 857,922 | 838,211 | 697,264 | 695,602 | 692,737 | 703,244 | 646,349 | 644,720 | 666,963 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $951,945K
= 0.00
Xencor Inc has consistently maintained a debt-to-assets ratio of 0.00 over the period from March 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt to finance its assets during this period. A debt-to-assets ratio of 0.00 signifies that the company's total assets are entirely funded by equity, implying a low financial risk and a strong financial position. Xencor Inc's consistent debt-free status suggests a prudent financial management approach and a stable capital structure that relies on equity financing.
Peer comparison
Dec 31, 2024
Company name
Symbol
Debt-to-assets ratio
Xencor Inc
XNCR
0.00
Abbott Laboratories
ABT
0.00
AbbVie Inc
ABBV
0.00
ACADIA Pharmaceuticals Inc
ACAD
0.00
Alkermes Plc
ALKS
0.00
Amphastar P
AMPH
0.39
ANI Pharmaceuticals Inc
ANIP
0.00
Arcus Biosciences Inc
RCUS
0.00
Biomarin Pharmaceutical Inc
BMRN
0.09
Bristol-Myers Squibb Company
BMY
0.51
Catalyst Pharmaceuticals Inc
CPRX
0.00